Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-01-23 @ 11:51 AM
Study NCT ID:
NCT02320058
Status:
COMPLETED
Last Update Posted:
2021-10-05
First Post:
2014-12-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-16
First Submit QC Date:
None
Study First Post Date:
2014-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-09-08
Results First Submit QC Date:
None
Results First Post Date:
2021-10-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-08
Last Update Post Date:
2021-10-05
Last Update Post Date Type:
ACTUAL